Viral Conjunctivitis Pipeline Insights 2017 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Viral Conjunctivitis - Pipeline Insights, 2017" report to their offering.

Viral Conjunctivitis - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Viral Conjunctivitis.

The This report covers the product profiles in various stages of development including Discovery, Pre - clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.

This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Viral Conjunctivitis.

This report also assesses the Viral Conjunctivitis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Key Topics Covered:

1. Viral Conjunctivitis Overview
2. Viral Conjunctivitis Disease Associated
3. Viral Conjunctivitis Pipeline Therapeutics
4. Viral Conjunctivitis Therapeutics under Development by Companies
5. Viral Conjunctivitis Filed and Phase III Products
6. Viral Conjunctivitis Phase II Products
7. Viral Conjunctivitis Phase I and IND Filed Products
8. Viral Conjunctivitis Discovery and Pre-Clinical Stage Products
9. Drug Candidate Profiles
10. Viral Conjunctivitis - Therapeutics Assessment
11. Viral Conjunctivitis - Discontinued Products
12. Viral Conjunctivitis - Dormant Products
13. Companies Involved in Therapeutics Development for Viral Conjunctivitis
14. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/6bcvxs/viral